Proteolytic activation of recombinant pro-memapsin 2 (pro-β-secretase) studied with new fluorogenic substrates Ermolieff, J.; Loy, J. A.; Koelsch, G.; Tang, J. BACE2, a β-secretase homolog, cleaves at the beta site and within the amyloid-β region of the amyloid-beta precursor protein. Memapsin 2 (β-secretase), a membrane-anchored aspartic protease, is involved in the cleavage of β-amyloid precursor protein to form β-amyloid peptide. Rob2d 51009464 4.0 driver. The primary structure of memapsin 2 suggests that it is synthesized in vivo as pro-memapsin 2 and converted to memapsin 2 by an activating protease [Lin et al. 97, 1456−1460]. Biotech Biopharmaceuticals. IL 1 An interleukin that is a primary trigger for the Immune response. Inhibited by anti -Inflammatory agents IL 4 An interleukin produced by T4 Helper cells stimulating activation of B cells into plasma cells. IL 2 An interleukin approved for renal cell carcinoma and metastatic melanoma, activating lymphoid lineages. Proteolytic activation of recombinant pro-memapsin 2 (Pro-beta-secretase) studied with new fluorogenic substrates. Biochemistry 39:6. (Correction to Figure 2 on p.12452 published in v.39 p.16263.).
Abstract
The paracaspase MALT1 is pivotal in antigen receptor–mediated lymphocyte activation and lymphomagenesis. MALT1 contains a caspase-like domain, but it is unknown whether this domain is proteolytically active. Here we report that MALT1 had arginine-directed proteolytic activity that was activated after T cell stimulation, and we identify the signaling protein Bcl-10 as a MALT1 substrate. Processing of Bcl-10 after Arg228 was required for T cell receptor–induced cell adhesion to fibronectin. In contrast, MALT1 activity but not Bcl-10 cleavage was essential for optimal activation of transcription factor NF-κB and production of interleukin 2. Thus, the proteolytic activity of MALT1 is central to T cell activation, which suggests a possible target for the development of immunomodulatory or anticancer drugs.
Access optionsAccess options
Subscribe to Journal
Get full journal access for 1 year
All prices include VAT for Germany.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
![]()
All prices are NET prices.
References
Proteolytic Activation Of Recombinant Pro-memapsin 2016Acknowledgements
We thank I. Gonzalez and D. Vercammen for discussions; S. Turcotte and L. Mury for technical assistance; V. Posevitz and P. Romero for culture reagents; A. Golks for technical advice on 'Anderson' gels; and F. Martinon and J. Tschopp for critically reading the manuscript. The plasmid pRDI_292 was a gift from R. Iggo (Swiss Institute for Experimental Cancer Research); Jurkat, Hut78 and Raji cells were gifts from O. Acuto (Pasteur Institute); phycoerythrin-labeled HLA-A*0201 peptide multimers were provided by P. Guillaume and I. Luescher (Ludwig Institute for Cancer Research); silencing vectors targeting the α- and β-subunit of IKK were provided by Y. Refaeli (National Jewish Medical and Research Center); and Jurkat cells deficient in IKKγ (NEMO) and their parental control cells were provided by A. Ting (Mount Sinai School of Medicine). Supported by the Swiss National Science Foundation (M.Th., N.F. and N.R.), the Swiss Cancer League (M.Th.), the Novartis Foundation (M.Th.), the Vontobel Stiftung (M.Th.), Studienstiftung des Deutschen Volkes (S.H.), the Faculty of Biology and Medicine of the University of Lausanne (S.H.) and the Swiss National Center of Competence in Research–Molecular Oncology (N.R.).
Author informationAuthor notes
Affiliations
Authors
Contributions
F.R. and S.H. designed, did and analyzed the key experiments; A.P.-F., M.Ta., R.M., O.G. and D.R. did experiments; M.G. provided technical assistance; E.M.I. and N.R. provided human antigen-specific CTLs; N.F. provided new reagents; M.Th. designed and organized the study and wrote the paper; and all authors discussed the results and commented on the manuscript.
Corresponding author
Correspondence to Margot Thome.
Proteolytic Activation Of Recombinant Pro-memapsin 2Supplementary informationPDF filesProteolytic Activation Of Recombinant Pro-memapsin 2017
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
About this article![]() Proteolytic Activation Of Recombinant Pro-memapsin 2 0Publication historyAcceptedDOIFurther reading
Proteolytic Activation Of Recombinant Pro-memapsin 2015Article Tools
Nature Immunology | Article
Proteolytic Activation Of Recombinant Pro-memapsin 2018T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |